Prognosis of Patients With Relapsed/Refractory Hodgkin Lymphoma Treated With IGEV Induction Therapy Before HDCT With AHSCT

NCT01478191 · clinicaltrials.gov ↗
COMPLETED
Status
495
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fondazione Italiana Linfomi - ETS